-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Upgrades Nevro to Neutral, Lowers Price Target to $5.85

Benzinga·02/07/2025 14:23:38
Listen to the news
Piper Sandler analyst Adam Maeder upgrades Nevro (NYSE:NVRO) from Underweight to Neutral and lowers the price target from $6 to $5.85.